EUVIMEDEUVIMED entdecken
VergleichsstudieÜbersichtsarbeit

Management of hypertension with fixed-dose triple-combination treatments

Benjamin J Epstein, Niren K Shah, Nancy L Borja-Hart

Therapeutic Advances in Cardiovascular Disease · 2013-10 · 7 (5) · 246-259

DOI: 10.1177/1753944713498638 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Therapeutic Advances in Cardiovascular Disease, online erschienen am 14.08.2013. Verfasst von Benjamin J Epstein und 2 weiteren Autor:innen. Beteiligte Einrichtung: University of Florida College of Pharmacy, Department of Pharmacotherapy and Translational Research, PO Box 100486, 1600 SW Archer Road, Gainesville,…. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 88 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The objective of this review is to evaluate the role of fixed-dose triple-combination therapy for the management of hypertension. An assessment of clinical trials showed that half the patients with hypertension have uncontrolled blood pressure (BP), with underlying factors including therapeutic inertia and poor patient adherence. Many patients will require three antihypertensive agents to achieve BP goals, and current guidelines recommend combining drugs with complementary mechanisms of action. Three single-pill triple-combination treatments are available and each includes an agent affecting the renin-angiotensin-aldosterone pathway (either a direct renin inhibitor or an angiotensin II receptor blocker) in combination with a calcium channel blocker and diuretic. These triple-combination therapies consistently demonstrated significantly greater BP reduction relative to the component dual combinations, with BP reductions documented across a range of patient populations. Triple-combination treatments were well tolerated in all clinical trials reviewed. The use of single-pill, triple-combination antihypertensive therapy has been shown to be an effective, well-tolerated, and convenient treatment strategy that can help patients achieve BP control.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antihypertensive AgentsBlood PressureCalcium Channel BlockersClinical Trials as TopicDiureticsDrug CombinationsHumansHypertensionPractice Guidelines as TopicRenin-Angiotensin SystemTreatment Outcome

Stichwörter der Autor:innen

aliskirenamlodipineantihypertensive agentsdrug combinationsfixed-dose triple-combination therapyhydrochlorothiazidehypertensionolmesartanvalsartan

Substanzen

Antihypertensive AgentsCalcium Channel BlockersDiureticsDrug Combinations

Autor:innen und Institutionen

  • University of Florida College of Pharmacy, Department of Pharmacotherapy and Translational Research, PO Box 100486, 1600 SW Archer Road, Gainesville, FL 32610, USA.

Zitieren

APA

Epstein, B. J., Shah, N. K., & Borja-Hart, N. L. (2013). Management of hypertension with fixed-dose triple-combination treatments. Therapeutic Advances in Cardiovascular Disease, 7(5), 246-259. https://doi.org/10.1177/1753944713498638

Vancouver

Epstein BJ, Shah NK, Borja-Hart NL. Management of hypertension with fixed-dose triple-combination treatments. Therapeutic Advances in Cardiovascular Disease. 2013;7(5):246-259. doi:10.1177/1753944713498638

BibTeX
@article{Epstein2013,
  author = {Epstein, Benjamin J and Shah, Niren K and Borja-Hart, Nancy L},
  title = {Management of hypertension with fixed-dose triple-combination treatments},
  journal = {Therapeutic Advances in Cardiovascular Disease},
  year = {2013},
  volume = {7},
  number = {5},
  pages = {246--259},
  doi = {10.1177/1753944713498638}
}
Kostenlos starten →